[Progressive infiltration of cranial nerves as first manifestation of primary meningeal lymphoma].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 8441285)

Published in Med Clin (Barc) on January 30, 1993

Authors

A Tortosa1, F Rubio, R Reñé, J Peres

Author Affiliations

1: Servicio de Neurología, Hospital de Bellvitge-Prínceps d'Espanya, Barcelona.

Articles by these authors

The protein phosphatase calcineurin is essential for NaCl tolerance of Saccharomyces cerevisiae. J Biol Chem (1994) 3.86

The metabolism of 5-fluorocytosine-2-14-C and of cytosine-14-C in the rat and the disposition of 5-fluorocytosine-2-14-C in man. Biochem Pharmacol (1966) 2.72

Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain (1997) 2.64

The Arabidopsis HKT1 gene homolog mediates inward Na(+) currents in xenopus laevis oocytes and Na(+) uptake in Saccharomyces cerevisiae. Plant Physiol (2000) 2.53

Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol (1997) 2.19

Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology (2000) 2.17

Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases. Arch Intern Med (1985) 2.08

The HAK1 gene of barley is a member of a large gene family and encodes a high-affinity potassium transporter. Plant Cell (1997) 2.06

Guidelines for the treatment of acute ischaemic stroke. Neurologia (2011) 2.05

Differential expression of two genes encoding isoforms of the ATPase involved in sodium efflux in Saccharomyces cerevisiae. Mol Gen Genet (1993) 1.90

Alkali cation selectivity of the wheat root high-affinity potassium transporter HKT1. Plant J (1996) 1.76

Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology (1992) 1.47

[Eagle syndrome and carotid dissection]. Neurologia (2010) 1.47

Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry (1996) 1.39

The effects of steroid therapy on pulmonary hypertension secondary to fibrosing mediastinitis. Cleve Clin J Med (1990) 1.39

Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol (2007) 1.32

Indolent anti-Hu-associated paraneoplastic sensory neuropathy. Neurology (1994) 1.20

Response: high-affinity potassium uptake in plants. Science (1996) 1.14

A multi-resistance plasmid isolated from commensal Neisseria species is closely related to the enterobacterial plasmid RSF1010. J Gen Microbiol (1986) 1.14

Cloning of two genes encoding potassium transporters in Neurospora crassa and expression of the corresponding cDNAs in Saccharomyces cerevisiae. Mol Microbiol (1999) 1.12

Analysis of automated methods for spatial normalization of lesioned brains. Neuroimage (2012) 1.10

Peduncular hallucinosis associated with posterior thalamic infarction. J Neurol (1992) 1.04

Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. Neuroreport (2000) 1.03

Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology (1999) 1.02

Comparative functional features of plant potassium HvHAK1 and HvHAK2 transporters. J Biol Chem (2001) 0.95

Neurosarcoidosis: report of 30 cases and a literature survey. Eur J Intern Med (2011) 0.95

Cerebral infarction of the basal ganglia due to embolism from the heart. Stroke (1984) 0.93

Determination of midazolam and two metabolites of midazolam in human plasma by gas chromatography--negative chemical-ionization mass spectrometry. J Chromatogr (1982) 0.91

Clinical outcome of spontaneous non-aneurysmal subarachnoid hemorrhage in 108 patients. Eur J Neurol (2011) 0.91

[Wernicke's encephalopathy in non-alcoholic patients: a series of 8 cases]. Neurologia (2011) 0.91

Urinary excretion of nitrosodimethylamine and nitrosoproline in humans: interindividual and intraindividual differences and the effect of administered ascorbic acid and alpha-tocopherol. Cancer Res (1986) 0.89

Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type. Neurologia (2011) 0.88

Paraneoplastic neuropathies. Eur Neurol (1993) 0.88

Prevalence of dementia subtypes in El Prat de Llobregat, Catalonia, Spain: the PRATICON study. Neuroepidemiology (2007) 0.87

Clinical practice guidelines in intracerebral haemorrhage. Neurologia (2011) 0.86

Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Mult Scler (2006) 0.86

Time-course phosphorylation of the mitogen activated protein (MAP) kinase group of signalling proteins and related molecules following middle cerebral artery occlusion (MCAO) in rats. Neuropathol Appl Neurobiol (2003) 0.85

Flumazenil for coma reversal in children after cannabis. Lancet (1993) 0.84

Giant basilar aneurysm in the course of subacute bacterial endocarditis. Stroke (1990) 0.84

Prevalence and European comparison of dementia in a ≥75-year-old composite population in Spain. Acta Neurol Scand (2011) 0.84

A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance. Cell Death Dis (2013) 0.83

Magnetic resonance imaging in neuro-Behçet's disease. Br J Rheumatol (1988) 0.83

High-performance liquid chromatographic determination of stereoselective disposition of carprofen in humans. J Pharm Sci (1981) 0.82

Pharmacokinetics of cefamandole in patients undergoing hemodialysis. Int J Clin Pharmacol Biopharm (1979) 0.82

An integrated simulator for surgery of the petrous bone. Stud Health Technol Inform (2001) 0.81

[Cerebellar infarction: prognosis and complications of vascular territories]. Neurologia (2012) 0.81

[Prevalence of vascular risk factors among Spanish populations aged 70 years and over, as reported in door-to-door studies on neurological diseases]. Neurologia (2007) 0.81

An antiserum identifying a red cell determinant expressed by Rh:33 and by some "new" depressed Rh phenotypes. Transfusion (1988) 0.81

[Plan for stroke healthcare delivery]. Neurologia (2006) 0.81

Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment. Neurologia (2012) 0.80

Balint's syndrome. Report of four cases with watershed parieto-occipital lesions from vertebrobasilar ischemia or systemic hypotension. Acta Neurol Belg (1983) 0.80

T cell subsets in multiple sclerosis: a serial study. Acta Neurol Scand (1995) 0.80

Reversible acute leukoencephalopathy as a form of presentation in cerebral amyloid angiopathy. J Neurol Sci (2009) 0.79

[Antiphospholipid syndrome in patients with ankylosing spondylitis. Presentation of 2 cases]. Med Clin (Barc) (1992) 0.78

Neuroimaging and biochemical markers in the three variants of primary progressive aphasia. Dement Geriatr Cogn Disord (2013) 0.78

Late-onset frontotemporal dementia associated with a novel PGRN mutation. J Neural Transm (Vienna) (2007) 0.78

Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style. Neurologia (2011) 0.78

Potassium starvation induces oxidative stress in Solanum lycopersicum L. roots. J Plant Physiol (2012) 0.78

Cerebrovascular events in cardiac catheterization. Stroke (1993) 0.78

[Polymicrogyria and ulegyria. Diagnosis by magnetic resonance]. Neurologia (1992) 0.78

Zinc ions block rectifier potassium channels and calcium activated potassium channels at the frog motor nerve endings. Brain Res (1994) 0.77

Metabolism of carprofen, a nonsteroid anti-inflammatory agent, in rats, dogs, and humans. J Pharm Sci (1980) 0.77

[Non-aneurysmal subarachnoid hemorrhage: 60 cases]. Neurologia (2006) 0.77

CSF somatostatin increase in patients with early parkinsonian syndrome. J Neural Transm Park Dis Dement Sect (1995) 0.77

Factors related to increased susceptibility to intestinal lesions with nonsteroidal anti-inflammatory agents in the lactating rat. Toxicol Appl Pharmacol (1980) 0.76

Familial Creutzfeldt-Jakob disease with E200K mutation presenting with neurosensorial hypoacusis. J Neurol Neurosurg Psychiatry (2007) 0.76

Antiganglioside antibodies in acute self-limiting ataxic neuropathy: incidence and significance. J Neuroimmunol (2001) 0.76

During intense exercise, obese women rely more than lean women on aerobic energy. Pflugers Arch (1998) 0.76

[The involvement of the parenchyma of the central nervous system in Behçet disease]. Rev Neurol (1998) 0.75

[Phenotyping Kell and Duffy antigens by a technic of coagglutination on the Groupamatic G 360]. Rev Fr Transfus Immunohematol (1982) 0.75

[Cerebrovascular accidents, a preventable failure of health care]. Rev Clin Esp (1987) 0.75

[Human leukocyte antigen and otosclerosis]. Acta Otorrinolaringol Esp (1996) 0.75

[Diplopia as an ischemic transient attack]. Neurologia (1993) 0.75

[Experimental studies on useful density in orthopantomography]. Ligament (1979) 0.75

Determination of acetyltrimoprostil and its metabolite trimoprostil in human or dog plasma by gas chromatography-negative-ion chemical ionization mass spectrometry. J Chromatogr (1985) 0.75

[Magnetic resonance imaging and Cogan's syndrome]. Rev Neurol (Paris) (1991) 0.75

[Pseudo-anti-N in patients undergoing maintenance hemodialysis]. Rev Fr Transfus Immunohematol (1977) 0.75

Pelvic dyskinesia with an outstanding response to tetrabenazine. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.75

Immunoassay method for the determination of pentachlorophenol in soil and sediment. Bull Environ Contam Toxicol (2006) 0.75

[Subarachnoid hemorrhage and anticoagulant treatment. Presentation of 2 cases associated with aneurysm]. Med Clin (Barc) (1992) 0.75

[Frontotemporal lobar degeneration: a descriptive study of 42 patients]. Neurologia (2008) 0.75

[Purely bulbar hematomas]. Rev Neurol (1998) 0.75

[Transcortical motor aphasia and motor negligence]. Neurologia (1990) 0.75

[Antiaggregation and anticoagulation in the prevention of cerebral infarction]. Rev Clin Esp (1996) 0.75

[Anti-Tr antibodies and cerebellar paraneoplastic degeneration associated with Hodgkin's disease]. Neurologia (1996) 0.75

Disposition of Dibekacin in patients undergoing haemodialysis. Eur J Clin Pharmacol (1980) 0.75

[Detection and identification of irregular anti-erythrocyte antibodies with the Groupamatic G 360. Adaptation to the routine]. Rev Fr Transfus Immunohematol (1980) 0.75

Determination of (-)-threo-chlorocitric acid in human plasma by gas chromatography-positive chemical-ionization mass spectrometry. J Chromatogr (1982) 0.75

Determination of imidazobenzodiazepine-3-carboxamide, a new anxiolytic agent, in human plasma by gas chromatography--negative chemical-ionization mass spectrometry. J Chromatogr (1982) 0.75

[Puerperal deep cerebral venous thrombosis]. Rev Neurol (2001) 0.75

Sciatic nerve injury in a renal-transplanted patient with avascular osteonecrosis. Nephron (1994) 0.75

[Primary intraventricular hemorrhage in a patient with unilateral moyamoya disease]. Neurologia (1992) 0.75

[Gonadal dysgenesis. Follow up with special attention to body height]. An Esp Pediatr (1988) 0.75

[Problems associated with the use of armored endotracheal tubes in children]. Rev Esp Anestesiol Reanim (1998) 0.75

Influence of antacids on the bioavailability of trimoprostil. Eur J Clin Pharmacol (1984) 0.75

[Cerebrovascular pathology: inpatient study in a community hospital. A prospective study]. Rev Neurol (1996) 0.75

Spectrofluorometric determination of substituted tetrahydrocarbazoles by a methylene blue sensitized photolytic reaction. J Pharm Sci (1977) 0.75